A pioneering approach to treating
central nervous system diseases

Welcome to Fullerene Therapeutics, Inc.,

formerly The Bronx Project, Inc.

Fullerene Therapeutics is a pioneering neuroscience pharmaceutical company engaged in developing Carboxyfullerenes. Its first developmental stage therapeutic drug, called C3, holds great promise for a wide variety of Central Nervous System diseases and other inflammatory conditions.

Next: Steps Essential for Phase 1

C3 has completed much of its preclinical discovery and development stages. Fullerene Therapeutics currently has an active Private Placement Memorandum raising funds for all steps up to and including completion of an FDA Phase 1 clinical trial in humans.

Copyright 2019 Fullerene Therapeutics, Inc.
No part of the contents of this web site may beĀ 
reproduced without express written permission.